Industry reports
Editor highlights

Gene Therapy Research Reports, April 2014

You might be interested in: hemophilia, cancer, medical equipment, more »


 

1-10 of 34 reports for Gene Therapy
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014', provides an overview of the Retinitis Pigmentosa ...

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Material into cells. The company's technologies are focused on broad range of areas like gene modulation, gene therapy, cell therapy, protein therapy and genetic vaccines. The company partnered with dr ...

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 96 drugs. gene therapy in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

MolMed S.p.A. (MLM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MolMed S.p.A. (MLM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Evaluated for the treatment of solid tumours. The company's in-house technology platforms include a cell and gene therapy, designed and developed for stable and transient production of retroviral vectors (rv ...

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening ...

DNAVEC Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNAVEC Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... The business of gene therapy, gene vaccine, therapeutic antibody, cell therapy, and other bio businesses. The company's core technologies include sendai virus vector (sev vector) and simian immunodeficiency ...

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... College london, royal free hospital, university of wurzburg and imperial college london. The company has collaboration with the center for cell and gene therapy at baylor college of medicine. Cell medica ...

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

... Of premature ovarian failure ii-34 mscs for gene therapy ii-35 msc therapy in the treatment of lung diseases ...

Bone Regeneration - Pipeline Review, H2 2013

Bone Regeneration - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.